A multi-center, Phase II trial of nab-paclitaxel and gemcitabine in patients with non-small-cell lung cancer previously treated with platinum-based chemotherapy

BACKGROUND: Nanoparticle albumin-bound paclitaxel (nab-PTX) plus gemcitabine (GEM) significantly improved overall survival in patients with metastatic pancreatic adenocarcinoma. Anti-tumor synergy between GEM and nab-PTX was recently demonstrated in a mouse model. We planned to assess the efficacy a...

Celý popis

Uloženo v:
Podrobná bibliografie
Vydáno v:Cancer Manag Res
Hlavní autoři: Tachihara, Motoko, Kiriu, Tatsunori, Hata, Akito, Hatakeyama, Yukihisa, Nakata, Kyosuke, Nagano, Tatsuya, Yamamoto, Masatsugu, Kobayashi, Kazuyuki, Ohnishi, Hisashi, Katakami, Nobuyuki, Nishimura, Yoshihiro
Médium: Artigo
Jazyk:Inglês
Vydáno: Dove 2019
Témata:
Clinical Trial Report
On-line přístup:https://ncbi.nlm.nih.gov/pmc/articles/PMC6681155/
https://ncbi.nlm.nih.gov/pubmed/31534366
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.2147/CMAR.S208224
Tagy: Přidat tag
Žádné tagy, Buďte první, kdo otaguje tento záznam!

Podobné jednotky